Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Reduced lopinavir exposure during pregnancy.

Stek AM, Mirochnick M, Capparelli E, Best BM, Hu C, Burchett SK, Elgie C, Holland DT, Smith E, Tuomala R, Cotter A, Read JS.

AIDS. 2006 Oct 3;20(15):1931-9.

PMID:
16988514
2.

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment.

Barragan P, Podzamczer D.

Expert Opin Pharmacother. 2008 Sep;9(13):2363-75. doi: 10.1517/14656566.9.13.2363 . Review.

PMID:
18710360
3.

[Penetration in reservoirs].

Pasquau Liaño J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:41-6. Review. Spanish.

PMID:
19572444
4.

Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.

Grub S, Delora P, Lüdin E, Duff F, Fletcher CV, Brundage RC, Kline MW, Calles NR, Schwarzwald H, Jorga K.

Clin Pharmacol Ther. 2002 Mar;71(3):122-30. Review.

PMID:
11907486
5.

Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review.

Eley T, Bertz R, Hardy H, Burger D.

Antivir Ther. 2013;18(3):361-75. doi: 10.3851/IMP2473. Epub 2012 Nov 26. Review.

PMID:
23676668
6.
7.

Transfer of antivirals across the human placenta.

Pacifici GM.

Early Hum Dev. 2005 Aug;81(8):647-54. Review.

PMID:
15946808
8.

Pharmacokinetics and safety of antimicrobial agents during pregnancy.

Chow AW, Jewesson PJ.

Rev Infect Dis. 1985 May-Jun;7(3):287-313. Review.

PMID:
3895351
9.

[Pharmacokinetics of ampicillin and cephalosporin in the bodies of pregnant women and parturients].

Shekhtman MM, Akhtamova ZM.

Akush Ginekol (Mosk). 1985 Jan;(1):9-11. Review. Russian. No abstract available.

PMID:
3156541
10.

On the use of partial AUC as an early exposure metric.

Dokoumetzidis A, Macheras P.

Eur J Pharm Sci. 2000 Apr;10(2):91-5. Review. No abstract available.

PMID:
10727873

Supplemental Content

Support Center